The compounded tirzepatide product is a copy of the active ingredient in Zepbound and Mounjaro, prepared the same way
In the USA, a poll conducted in May 2024 ( n = 1479) found that 6% of adults were currently using a GLP-1 or GLP-1/GIP medication and 12% had ever used one [15]
Compounding pharmacies have been allowed to make compounded semaglutide the active ingredient in the blockbuster drugs due to a short supply of the brand name medications that started in 2022
GLP-1 Medical Weight Loss Program The GLP-1 medical weight loss program is a clinically supervised treatment designed to support fat reduction, appetite control, and metabolic health
"They kept talking about the weight loss injections and I was like, 'We don't even do that'," he said
Our expert medical team offers a proven solution: Semaglutide-based weight loss injections the same science behind brand names like Ozempic and Wegovy